The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
The Adjuvants Aluminum Hydroxide and MF59 Induce Monocyte and Granulocyte Chemoattractants and Enhance Monocyte Differentiation toward Dendritic Cells
Open accessAbstract
Aluminum hydroxide (alum) and the oil-in-water emulsion MF59 are widely used, safe and effective adjuvants, yet their mechanism of action is poorly understood. We assessed the effects of alum and MF59 on human immune cells and found that both induce secretion of chemokines, such as CCL2 (MCP-1), CCL3 (MIP-1α), CCL4 (MIP-1β), and CXCL8 (IL-8), all involved in cell recruitment from blood into peripheral tissue. Alum appears to act mainly on macrophages and monocytes, whereas MF59 additionally targets granulocytes. Accordingly, monocytes and granulocytes migrate toward MF59-conditioned culture supernatants. In monocytes, both adjuvants lead to increased endocytosis, enhanced surface expression of MHC class II and CD86, and down-regulation of the monocyte marker CD14, which are all phenotypic changes consistent with a differentiation toward dendritic cells (DCs). When monocyte differentiation into DCs is induced by addition of cytokines, these adjuvants enhanced the acquisition of a mature DC phenotype and lead to an earlier and higher expression of MHC class II and CD86. In addition, MF59 induces further up-regulation of the maturation marker CD83 and the lymph node-homing receptor CCR7 on differentiating monocytes. Alum induces a similar but not identical pattern that clearly differs from the response to LPS. This model suggests a common adjuvant mechanism that is distinct from that mediated by danger signals. We conclude that during vaccination, adjuvants such as MF59 may increase recruitment of immune cells into the injection site, accelerate and enhance monocyte differentiation into DCs, augment Ag uptake, and facilitate migration of DCs into tissue-draining lymph nodes to prime adaptive immune responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Monocyte and macrophage heterogeneity
Gordon, S., & Taylor, P. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1733 · Cited by 5,190
Innate Immunity: The Virtues of a Nonclonal System of Recognition
Medzhitov, R., & Janeway, C. A. (1997) · Cell · doi:10.1016/s0092-8674(00)80412-2 · Cited by 2,434
The Instructive Role of Innate Immunity in the Acquired Immune Response
Fearon, D. T., & Locksley, R. M. (1996) · Science · doi:10.1126/science.272.5258.50 · Cited by 1,719
Boring, L., Gosling, J., Chensue, S. W., Kunkel, S. L., Farese, R. V., Broxmeyer, H. E., & Charo, I. F. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119798 · Cited by 1,096
IL-6 switches the differentiation of monocytes from dendritic cells to macrophages
Chomarat, P., Banchereau, J., Davoust, J., & Karolina Palucka, A. (2000) · Nature Immunology · doi:10.1038/82763 · Cited by 906
Castellino, F., Huang, A. Y., Altan-Bonnet, G., Stoll, S., Scheinecker, C., & Germain, R. N. (2006) · Nature · doi:10.1038/nature04651 · Cited by 855
Differentiation of Monocytes into Dendritic Cells in a Model of Transendothelial Trafficking
Randolph, G. J., Beaulieu, S., Lebecque, S., Steinman, R. M., & Muller, W. A. (1998) · Science · doi:10.1126/science.282.5388.480 · Cited by 809
Adjuvant-Enhanced Antibody Responses in the Absence of Toll-Like Receptor Signaling
Gavin, A. L., Hoebe, K., Duong, B., Ota, T., Martin, C., Beutler, B., & Nemazee, D. (2006) · Science · doi:10.1126/science.1135299 · Cited by 581
Recent advances in the discovery and delivery of vaccine adjuvants
O'Hagan, D. T., & Valiante, N. M. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1176 · Cited by 434
Self-citationDendritic Cells as the Terminal Stage of Monocyte Differentiation
Palucka, K. A., Taquet, N., Sanchez-Chapuis, F., & Gluckman, J. C. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.9.4587 · Cited by 378
Luft, T., Jefford, M., Luetjens, P., Toy, T., Hochrein, H., Masterman, K.-A., Maliszewski, C., Shortman, K., Cebon, J., & Maraskovsky, E. (2002) · Blood · doi:10.1182/blood-2001-12-0360 · Cited by 358
The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine
Podda, A. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00499-0 · Cited by 333
Adjuvant Properties of Aluminum and Calcium Compounds
Gupta, R. K., Rost, B. E., Relyveld, E., & Siber, G. R. (1995) · Pharmaceutical Biotechnology · doi:10.1007/978-1-4615-1823-5_8 · Cited by 330
Dauer, M., Obermaier, B., Herten, J., Haerle, C., Pohl, K., Rothenfusser, S., Schnurr, M., Endres, S., & Eigler, A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.8.4069 · Cited by 319
The Multiple Personalities of the Chemokine Receptor CCR7 in Dendritic Cells
Sánchez-Sánchez, N., Riol-Blanco, L., & Rodríguez-Fernández, J. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.9.5153 · Cited by 273
Seeking wisdom in innate immunity
Fearon, D. T. (1997) · Nature · doi:10.1038/40967 · Cited by 267
Promotion of B Cell Immune Responses via an Alum-Induced Myeloid Cell Population
Jordan, M. B., Mills, D. M., Kappler, J., Marrack, P., & Cambier, J. C. (2004) · Science · doi:10.1126/science.1089926 · Cited by 248
Ulanova, M., Tarkowski, A., Hahn-Zoric, M., & Hanson, L. Å. (2001) · Infection and Immunity · doi:10.1128/iai.69.2.1151-1159.2001 · Cited by 239
Women Fight Uphill Battle for Equity
Kinoshita, J. (1996) · Science · doi:10.1126/science.274.5284.50 · Cited by 213
Dendritic Cells Internalize Vaccine Adjuvant after Intramuscular Injection
Dupuis, M., Murphy, T. J., Higgins, D., Ugozzoli, M., van Nest, G., Ott, G., & McDonald, D. M. (1998) · Cellular Immunology · doi:10.1006/cimm.1998.1283 · Cited by 185
Mannhalter, J. W., Neychev, H., Zlabinger, G. J., Ahmad, R., & Eibl, M. M. (1985) · PubMed Central · Cited by 183
Rimaniol, A., Gras, G. S., Verdier, F., Capel, F., Grigoriev, V. B., Porcheray, F., Sauzeat, E., Fournier, J. G., Clayette, P., Siegrist, C., et al. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.01.061 · Cited by 157
Immunization with the adjuvant MF59 induces macrophage trafficking and apoptosis
Dupuis, M., Denis-Mize, K. S., LaBarbara, A., Peters, W., Charo, I. F., McDonald, D. M., & Ott, G. S. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(2001010)31:10<2910::aid-immu2910>3.0.co;2-3 · Cited by 145
Zou, W., Borvak, J., Marches, F., Wei, S., Galanaud, P., Émilie, D., & Curiel, T. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.8.4388 · Cited by 139
Distribution of adjuvant MF59 and antigen gD2 after intramuscular injection in mice
Dupuis, M. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00263-7 · Cited by 123
Demonstration and phenotypic characterization of resident macrophages in rat skeletal muscle.
Honda, H., Kimura, H., & Rostami, A. M. (1990) · PubMed Central · Cited by 107
Rotta, G., Edwards, E. W., Sangaletti, S., Bennett, C. L., Ronzoni, S., Colombo, M. P., Steinman, R. M., Randolph, G. J., & Rescigno, M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030335 · Cited by 107
Singh, M., Ugozzoli, M., Kazzaz, J., Chesko, J., Soenawan, E., Mannucci, D., Titta, F., Contorni, M., Volpini, G., & Guidice, G. D. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.09.046 · Cited by 92
O’Hagan, D. T., Wack, A., & Podda, A. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100402 · Cited by 90
Self-citationRecent advances in vaccine adjuvants: the development of MF59 emulsion and polymeric microparticles
O’Hagan, D. T., Ott, G. S., & Nest, G. V. (1997) · Molecular Medicine Today · doi:10.1016/s1357-4310(96)10058-7 · Cited by 88
Self-citationTLR4 agonists as immunomodulatory agents
Alderson, M. R., McGowan, P., Baldridge, J. R., & Probst, P. (2006) · Journal of Endotoxin Research · doi:10.1179/096805106x118753 · Cited by 80
Luft, T., Maraskovsky, E., Schnurr, M. M., Knebel, K., Kirsch, M., Görner, M., Skoda, R. C., Ho, A. D., Nawroth, P. P., & Bierhaus, A. (2004) · Blood · doi:10.1182/blood-2003-12-4146 · Cited by 73
Bartz, H., Avalos, N., Baetz, A., Heeg, K., & Dalpke, A. (2006) · Blood · doi:10.1182/blood-2006-03-008946 · Cited by 70
Lipopolysaccharide can block the potential of monocytes to differentiate into dendritic cells
Palucka, K. A., Taquet, N., Sanchez, F., & Gluckman, J. C. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.65.2.232 · Cited by 48
MF59: a safe and potent adjuvant for human use
Podda, A., Giudice, G. D., & O’Hagan, D. T. (2006) · Elsevier eBooks · doi:10.1016/b978-012088403-2/50010-1 · Cited by 31
Self-citation
Cited by
Vaccine Adjuvants: Putting Innate Immunity to Work
Coffman, R. L., Sher, A., & Seder, R. A. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.002 · Cited by 1,924
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
Chaudhary, N., Weissman, D., & Whitehead, K. A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00283-5 · Cited by 1,555
Key roles of adjuvants in modern vaccines
Reed, S. G., Orr, M. T., & Fox, C. B. (2013) · Nature Medicine · doi:10.1038/nm.3409 · Cited by 1,419
Emerging concepts in the science of vaccine adjuvants
Pulendran, B., S. Arunachalam, P., & O’Hagan, D. T. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00163-y · Cited by 1,385
Self-citationZhao, L., Seth, A., Wibowo, N., Zhao, C.-X., Mitter, N., Yu, C., & Middelberg, A. P. J. (2014) · Vaccine · doi:10.1016/j.vaccine.2013.11.069 · Cited by 919
Metadata
- Authors
- Seubert, A., Monaci, E., Pizza, M., O’Hagan, D. T., & Wack, A.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-04
- Volume
- 180
- Issue
- 8
- Pages
- 5402-5412
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1543572242
- Cited by
- 430
- References
- 35
- FWCI
- 10.54
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.